tirzepatide side effects indigestion for Weight Loss GLP-1 and GIP-1 receptor agonists
Description
Coprimary end points were the percentage change in weight from baseline and a weight reduction of 5% or more
While this sounds very promising, it is also important to remember that these results occurred in patients enrolled in a study where they were closely monitored
6A, and B)
Schneeweiss, S
Adiposity and body-composition endpoints: Both are relevant
Receive an e-prescription sent directly to your preferred pharmacy if clinically appropriate
